Rani Therapeutics Holdings, Inc. (RANI) has entered into a securities purchase agreement with a single institutional investor for the sale of 4,354,000 shares of its Class A common stock at $0.40 per share.
The gross proceeds from this offering are expected to be approximately $3.0 million. The offering is anticipated to close on or around July 16, 2025.
